Get the Stockscreener App
1.90
2.56%
-0.05
After Hours:
1.93
0.03
+1.58%
Spero Therapeutics Inc stock is traded at $1.90, with a volume of 391.23K.
It is down -2.56% in the last 24 hours and down -19.49% over the past month.
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
See More
Previous Close:
$1.95
Open:
$1.96
24h Volume:
391.23K
Relative Volume:
0.45
Market Cap:
$106.92M
Revenue:
$76.19M
Net Income/Loss:
$-1.61M
P/E Ratio:
190.00
EPS:
0.01
Net Cash Flow:
$28.98M
1W Performance:
-11.63%
1M Performance:
-19.49%
6M Performance:
+153.81%
1Y Performance:
+42.86%
1-Day Range:
$1.89
$1.9883
1-Week Range:
$1.86
$2.18
52-Week Range:
$0.5052
$3.22
Spero Therapeutics Inc Stock (SPRO) Company Profile
Name
Spero Therapeutics Inc
Sector
Industry
Phone
857-242-1600
Address
675 MASSACHUSETTS AVENUE, CAMBRIDGE, MA
Compare SPRO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SPRO
Spero Therapeutics Inc
|
1.90 | 109.17M | 76.19M | -1.61M | 28.98M | 0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Spero Therapeutics Inc Stock (SPRO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-23-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-01-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-16-20 | Initiated | Berenberg | Buy |
| Sep-29-20 | Initiated | Evercore ISI | Outperform |
| Nov-05-19 | Reiterated | H.C. Wainwright | Buy |
| Sep-09-19 | Initiated | Janney | Buy |
| Feb-09-18 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-27-17 | Initiated | BofA/Merrill | Neutral |
| Nov-27-17 | Initiated | Oppenheimer | Outperform |
| Nov-27-17 | Initiated | Stifel | Buy |
View All
Spero Therapeutics Inc Stock (SPRO) Latest News
Will Spero Therapeutics Inc. stock outperform tech sector in 2025July 2025 Setups & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Spero Therapeutics, Inc. (NASDAQ:SPRO) Short Interest Down 32.8% in August - MarketBeat
Does Spero Therapeutics Inc. have pricing powerQuarterly Trade Review & Low Risk Growth Stock Ideas - Lancaster City Council
What is Spero Therapeutics Inc.’s valuation compared to sector2025 Market WrapUp & AI Based Buy/Sell Signal Reports - Lancaster City Council
Will Spero Therapeutics Inc. outperform its industry peersMarket Performance Recap & Weekly Consistent Profit Watchlists - beatles.ru
Spero Therapeutics (NASDAQ:SPRO) Director Sells $12,946.84 in Stock - MarketBeat
Should you buy the dip on Spero Therapeutics Inc.2025 Breakouts & Breakdowns & Smart Allocation Stock Reports - beatles.ru
Is Spero Therapeutics Inc. a good stock for dollar cost averaging2025 Growth vs Value & Low Drawdown Trading Strategies - beatles.ru
Multi asset correlation models including Spero Therapeutics Inc.Weekly Trade Recap & Risk Controlled Swing Trade Alerts - Newser
Sentiment analysis tools applied to Spero Therapeutics Inc.2025 Earnings Impact & Reliable Price Action Trade Plans - Newser
Signal strength of Spero Therapeutics Inc. stock in tech scannersDip Buying & Free Fast Entry Momentum Trade Alerts - Newser
Can Spero Therapeutics Inc. lead its sector in growthJuly 2025 Weekly Recap & Weekly Top Stock Performers List - خودرو بانک
Why Spero Therapeutics Inc. is moving todayWeekly Stock Analysis & Community Consensus Picks - Newser
Analyzing recovery setups for Spero Therapeutics Inc. investors2025 Price Targets & Weekly Stock Breakout Alerts - Newser
How sentiment analysis helps forecast Spero Therapeutics Inc.Sell Signal & Verified Stock Trade Ideas - Newser
Is Spero Therapeutics Inc. exposed to currency risksQuarterly Market Review & Risk Controlled Daily Trade Plans - خودرو بانک
Ranking Spero Therapeutics Inc. among high performing stocks via toolsMarket Movement Recap & Safe Entry Zone Identification - Newser
Is Spero Therapeutics Inc. a candidate for recovery playGap Down & Weekly Watchlist for Hot Stocks - Newser
Technical signs of recovery in Spero Therapeutics Inc.Weekly Gains Summary & Daily Chart Pattern Signals - Newser
What candlestick patterns are forming on Spero Therapeutics Inc.Quarterly Profit Summary & Verified Momentum Stock Alerts - Newser
Comparing Spero Therapeutics Inc. in custom built stock radarsJuly 2025 Earnings & Low Risk Entry Point Guides - Newser
Trend analysis for Spero Therapeutics Inc. this weekEntry Point & AI Forecasted Entry/Exit Points - Newser
Risk vs reward if holding onto Spero Therapeutics Inc.July 2025 Spike Watch & Growth Focused Stock Reports - Newser
Using data models to predict Spero Therapeutics Inc. stock movementMarket Risk Report & Free High Accuracy Swing Entry Alerts - Newser
Live market analysis of Spero Therapeutics Inc.Weekly Gains Report & Risk Controlled Stock Pick Alerts - Newser
What data driven models say about Spero Therapeutics Inc.’s futureInflation Watch & Verified Short-Term Trading Plans - Newser
Price momentum metrics for Spero Therapeutics Inc. explained2025 Technical Patterns & Long-Term Safe Investment Plans - Newser
Spero therapeutics (SPRO): COO Keutzer sells $3.3k in stock - Investing.com India
Mahadevia Ankit sells Spero Therapeutics (SPRO) stock worth $12946 By Investing.com - Investing.com Canada
Is Spero Therapeutics Inc. subject to activist investor interestWeekly Risk Report & Real-Time Volume Trigger Notifications - خودرو بانک
Spero Therapeutics Inc. stock chart pattern explained2025 Year in Review & Momentum Based Trading Ideas - Newser
Earnings visualization tools for Spero Therapeutics Inc.July 2025 Fed Impact & Expert Approved Momentum Trade Ideas - Newser
Published on: 2025-09-03 19:52:17 - beatles.ru
Aug Drivers: Can Spero Therapeutics Inc. lead its sector in growthTrade Performance Summary & Step-by-Step Swing Trade Plans - خودرو بانک
Mahadevia Ankit sells Spero Therapeutics (SPRO) stock worth $12946 - Investing.com
What institutional flow reveals about Spero Therapeutics Inc.2025 Trade Ideas & Consistent Growth Equity Picks - Newser
Spero therapeutics (SPRO): COO Keutzer sells $3.3k in stock By Investing.com - Investing.com UK
Custom strategy builders for tracking Spero Therapeutics Inc.2025 Support & Resistance & Low Risk High Reward Trade Ideas - Newser
Applying sector rotation models to Spero Therapeutics Inc.2025 Historical Comparison & Reliable Trade Execution Plans - Newser
Spero Therapeutics Inc Stock (SPRO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):